Your session is about to expire
← Back to Search
Aromatherapy for Breast and Prostate Cancer
N/A
Waitlist Available
Led By Amy M Ross, Ph.D.
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Criteria for solid tumors: Participants must have measurable disease, per MD and data in medical record
Participants must have histologically or cytologically confirmed hormone receptor positive (HR+) HER2 negative (-) breast cancer or prostate cancer (hormone therapy excepted) who are in Stage I-III with or without evidence of metastasis using the Cancer Therapy Evaluation Program (CTEP) Simplified Disease Classification
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at day 3 or 4 and on day 7
Awards & highlights
Study Summary
This trial uses virtual reality and smells to study if it can improve the immune system for cancer patients who have completed chemo or radiation therapy.
Who is the study for?
This trial is for adults over 18 who were diagnosed with stage I-III hormone receptor positive, HER2 negative breast or prostate cancer within the last year. They must understand and consent to the study, have measurable disease, and no history of autoimmune diseases. Smokers or those with recent infections, surgeries, asthma, allergies to citrus peel or pine forests are excluded.Check my eligibility
What is being tested?
The study tests if aromatherapy using humidified forest oils can boost immune cells in patients who've completed chemo/radiation therapy for early-stage breast or prostate cancer. It aims to simulate forest therapy indoors for those unable to engage in outdoor activities.See study design
What are the potential side effects?
Potential side effects may include contact dermatitis (skin irritation) and coughing due to reactions from the forest oils used during aromatherapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My solid tumor can be measured by my doctor.
Select...
My breast or prostate cancer is hormone receptor positive and HER2 negative, at Stage I-III.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and at day 3 or 4 and on day 7
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at day 3 or 4 and on day 7
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Humidified phytoncides to simulate the forest greenspace immersion (SFIT)
Secondary outcome measures
Collecting and analyzing immune system measures while deploying the simulated forest immersion therapy with forest oils
Trial Design
1Treatment groups
Experimental Treatment
Group I: Supportive care (SFIT, biospecimen, interview)Experimental Treatment1 Intervention
Patients participate in SFIT, using humidified wood and fragrance oils, over 1 hour. on day 1, day 3 or 4 and on day 7. Patients also undergo blood sample collection at baseline and on days 3 or 4 and 7 and participate in interviews at baseline and post-treatment.
Find a Location
Who is running the clinical trial?
OHSU Knight Cancer InstituteLead Sponsor
231 Previous Clinical Trials
2,090,638 Total Patients Enrolled
14 Trials studying Breast Cancer
2,317 Patients Enrolled for Breast Cancer
Oregon Health and Science UniversityOTHER
979 Previous Clinical Trials
7,386,431 Total Patients Enrolled
5 Trials studying Breast Cancer
396 Patients Enrolled for Breast Cancer
Amy M Ross, Ph.D.Principal InvestigatorOHSU Knight Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not had a fever or infection in the last two weeks.My solid tumor can be measured by my doctor.You cannot have asthma because forest oils might make your asthma worse.I had surgery or an invasive procedure within the last two months.I have an autoimmune disease or am on immune-modulating therapies.I am 18 years old or older.I cannot complete all study requirements.My first breast or prostate cancer diagnosis was over a year ago.My breast or prostate cancer is hormone receptor positive and HER2 negative, at Stage I-III.I cannot smell common scents from commercial fragrances.You cannot use tobacco or smoke within 1 hour of the start of the study. This is because the oils in the forest can cause skin irritation and coughing.I was diagnosed with breast or prostate cancer less than a year ago.You have an allergy to citrus peel or pine forests, which can cause skin irritation and coughing.
Research Study Groups:
This trial has the following groups:- Group 1: Supportive care (SFIT, biospecimen, interview)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger